Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Lymphoma 4Hodgkin Disease 3Oligodendroglioma 2Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Glioma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 8Radiotherapy 7Radiation 3Magnetic Resonance Spectroscopy 3Biopsy 3Vincristine 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Procarbazine 2Lomustine 2vorasidenib 1vocimagene amiretrorepvec 1trametinib 1pemigatinib 1pembrolizumab 1mirdametinib 1fluorodopa F 18 1dabrafenib 1abexinostat 1abemaciclib 1Vorinostat 1Tretinoin 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Standard of Care 1Spinal Puncture 1Restraint, Physical 1Radiotherapy, Conformal 1Protons 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Oligodendroglioma × Procarbazine × 1 year × Clear all
NCT05331521 2026-02-03

ImproveCodel

University Hospital Heidelberg

Phase 3 Recruiting
406 enrolled
CNS

Oligodendroglioma

NCT00887146 2026-01-22

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
305 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡